Connecting for innovation and impact for all in global health

contact us
Membership
Subscribe

Search

Stanford University
MEMBERS
Show Members
TOPICS
REGIONS
Moving Beyond IRR to Social Value

Moving Beyond IRR to Social Value

Join Stanford Biodesign for a discussion that goes beyond the traditional healthcare model to involve public health, economics, community engagement, policy, and more. Sara Olsen, founder of SVT Group ― an advisory firm that supports clients to measure their social and environmental impact ― will discuss what impact assessment is, the emerging discipline of impact management and valuation, why it is specifically important in health care, and what some useful tools and resources are to help you bring your whole vision forward as you scale.

The Potential of GenAI for Health Behavior Change | Key Takeaways from the White Paper Virtual Launch

The Potential of GenAI for Health Behavior Change | Key Takeaways from the White Paper Virtual Launch

On March 26, the Bay Area Global Health Alliance hosted a virtual launch event for the recently released white paper, Generative AI for Health in Low and Middle-Income Countries, showcasing research conducted by Stanford Center for Digital Health (CDH), with support from Advancing Health Online (AHO). The discussion explored the five key findings from the research: 1) sharing learnings, 2) focusing on actionable measurement, 3) improving language and localization, 4) improving technical capacity and shared infrastructure, and 5) improving digital and basic health infrastructure.

Tackling AMR with Outcomes-Based Financing: Findings from Tanzania and Senegal

Tackling AMR with Outcomes-Based Financing: Findings from Tanzania and Senegal

On February 25, Neha Agarwal, senior director of strategy at PATH and Alliance board vice chair, led a session for Stanford Mussallem Center for Biodesign’s Innovation and Health Equity Series. She discussed how outcomes-based financing (OBF) can be leveraged to tackle antimicrobial resistance (AMR). Her talk, which provided a first look at data from a year-long study in Tanzania and Senegal, emphasized how innovative financing mechanisms could reshape global health strategies.

White Paper Virtual Launch Event

White Paper Virtual Launch Event

Join us virtually on Wednesday, March 26 from 8:30-10:00 AM PT as we review the five key findings of the recently released white paper “GenAI for Health in LMICs,” hear from implementers in the field, and invite perspectives of funders looking at how to fill the gaps.

New White Paper Explores GenAI’s Potential on Health Behavior Change in LMICs

New White Paper Explores GenAI’s Potential on Health Behavior Change in LMICs

As the potential impact of generative AI (GenAI) on health in low- and middle-income countries (LMICs) continues to be explored, two key questions emerge: Where is GenAI currently being used most effectively, and how can its full potential be unlocked for greater impact, both for behavior change and broader healthcare applications? A newly released white paper sheds light on these questions, offering insights from a comprehensive review led by the Stanford Center for Digital Health (CDH) with support from Advancing Health Online (AHO) and the Bay Area Global Health Alliance as lead dissemination partner.

The 2025 Stanford Global Health Conference

The 2025 Stanford Global Health Conference

Hosted by Stanford’s Center for Innovation in Global Health and Mussallem Center for Biodesign, this annual conference is the culmination of MED232: Global Health – Scaling Health Technology Innovations in Low-Resource Settings, a course that unites students, faculty, and global health changemakers in tackling barriers to equitable healthcare access. This year’s theme focuses on the critical challenges of scaling health innovations for lasting impact—moving beyond technological breakthroughs to address the cultural, economic, and logistical barriers that hinder widespread adoption in under-resourced settings.

Outcomes-Based Finance as a Tool for Health Equity and Innovation

Outcomes-Based Finance as a Tool for Health Equity and Innovation

Join Stanford Mussallem Center for Biodesign on February 25 for the next session in their Innovation and Health Equity Discussion Series where Neha Agarwal, senior director of strategy at PATH and Alliance board vice chair, will discuss an innovative outcomes-based financing (OBF) mechanism being developed in partnership with the governments of Tanzania and Senegal, the Bay Area Global Health Alliance, and Pfizer to reinforce antimicrobial stewardship efforts in LMICs.

From the Innovators Workbench: Biodesign in India

From the Innovators Workbench: Biodesign in India

Join Stanford Biodesign to hear from two of the Stanford-India Biodesign initiative’s architects and an early alumna. How did they lay the groundwork for the program? What are the opportunities and challenges inherent in a collaboration with the government? How did the need for cost-effective technologies influence the innovation approach? And how did they catalyze the work of funders, suppliers, manufacturers, distributors, and purchasers required to get the inventions to patients? They will discuss their biggest takeaways from this entrepreneurial endeavor, the potential to replicate it in other resource-constrained environments, and what excites them most about the future of healthtech innovation in India.

Beyond the Flames: The Health Risks of Wildfires

Beyond the Flames: The Health Risks of Wildfires

“The air [after a wildfire] contains tiny particles from burning fossil fuels, homes, and even pesticides, which are linked to cancer, cardiac damage, and respiratory issues,” said Dr. Lisa Patel of Stanford in an interview with Katie Couric highlighting the severe...

Rosenkranz Global Health Policy Research Symposium

Rosenkranz Global Health Policy Research Symposium

The 4th annual Rosenkranz Global Health Policy Research Symposium at Stanford University will be held on Tuesday, May 20, 2025. The Symposium is a day-long event that showcases innovative global health policy research from academics around the world. The keynote speaker will be Sir Peter Piot, a prominent leader in global health policy and practice.

50 by 50: Halving Premature Deaths Globally by 2050 | A Bay Area Launch Event for the Lancet Global Health 2050 Report

50 by 50: Halving Premature Deaths Globally by 2050 | A Bay Area Launch Event for the Lancet Global Health 2050 Report

On January 22, UCSF, UC Berkeley, Stanford University, and the Bay Area Global Health Alliance co-hosted the Bay Area launch of the Lancet Commission on Investing in Health report, “Global Health 2050: The Path to Halving Premature Death by Mid-Century.” This event brought together Bay Area students, researchers, and other key stakeholders to explore the significant findings of the Lancet report, discuss next steps, and outline the priorities for follow-up studies.

Dual Market Returns: Healthcare Investment in Emerging Markets | JPM 2025

Dual Market Returns: Healthcare Investment in Emerging Markets | JPM 2025

On Wednesday, January 15, the Bay Area Global Health Alliance hosted a panel discussion, “Realizing Returns: Investment Opportunities in Emerging Markets,” at the 2025 J.P. Morgan Healthcare Conference (JPM) in San Francisco, followed by a reception to continue the conversation, “Private Sector Finance for Global Health: Investing for Impact and Equity,” held at Accenture San Francisco Innovation Hub. Together, these discussions explored investment opportunities in global health and partnerships using innovative financing models to drive both business and social returns in emerging markets.